Molina Healthcare Inc vs Merck & Company, Inc. — Stock Comparison

Molina Healthcare Inc (MOH) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

Q·Score Winner
Merck & Company, Inc.
MRK6.9/10vs 3.9/10

Merck & Company, Inc. holds a significant lead over Molina Healthcare Inc on Q·Score (6.9 vs 3.9 out of 10), led by Growth (6.2 vs 1.7) and Quality (7.7 vs 4.2). Analyst consensus targets imply greater upside for MRK (+7.1%) than for MOH (-15.4%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
MOHMRK

Q·Score Breakdown

3.9
Very Bearish
Overall
6.9
Neutral
4.2
Quality
7.7
6.1
Health
7
1.7
Growth
6.2
3.8
Valuation
6.4
3.6
Sentiment
7
MOH

Healthy balance sheet and financial position.

revenue declining 4% year-over-year.

MRK

High-quality business with 19% return on equity and 14% profit margins.

Analyst Consensus

Neutral
-15.4%
Target $197.35
17 analysts
Bullish
+7.1%
Target $132.33
27 analysts

Fundamentals

MOH
MRK
62.5×
Trailing P/E
34.8×
25.4×
Forward P/E
12.9×
0.44%
Profit Margin
13.59%
8.86%
Gross Margin
76.73%
4.48%
ROE
18.94%
-4.30%
Revenue Growth
4.90%
-95.00%
Earnings Growth
0.74
Beta
0.20
Dividend Yield
2.75%
$12.2B
Market Cap
$305.1B
52-Week Range
MOH
$12192% of range$244
MRK
$7787% of range$130

Frequently Asked Questions

MOH vs MRK: which stock scores better overall?

Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.9/10 versus Molina Healthcare Inc (MOH) at 3.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: MOH or MRK?

Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 1.7/10). Molina Healthcare Inc reports revenue growth (-4.3% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is MOH or MRK more attractively valued?

Merck & Company, Inc. (MRK) scores higher on Valuation (6.4/10 vs 3.8/10). MOH trades at 25.4× P/E versus MRK at 12.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about MOH vs MRK?

There are 17 analysts covering MOH with a consensus price target of $197.35, and 27 analysts covering MRK with a consensus target of $132.33. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: MOH or MRK?

Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 4.2/10). Net profit margin: MOH at 0.4%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: MOH or MRK?

Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6.1/10). Market beta: MOH at 0.74, MRK at 0.20. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of MOH and MRK?

Molina Healthcare Inc (MOH) has a market capitalisation of $12.2B, while Merck & Company, Inc. (MRK) has a market cap of $305.1B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do MOH or MRK pay dividends?

MOH does not currently pay a dividend, while MRK pays a dividend yield of 2.75%. Dividend yields fluctuate with share price and company payout decisions.

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026